ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)

ClinicalTrials.gov ID: NCT00413283

Public ClinicalTrials.gov record NCT00413283. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 6:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2, Randomized, Double Blind, Placebo-Controlled Dose and Schedule Finding Trial to Evaluate the Safety and Efficacy of AMG 531 For Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Advanced Non-Small Cell Lung Cancer Already Receiving Gemcitabine and Platinum.

Study identification

NCT ID
NCT00413283
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Amgen
Industry
Enrollment
63 participants

Conditions and interventions

Interventions

  • Carboplatin Drug
  • Cisplatin Drug
  • Gemcitabine Drug
  • Placebo Drug
  • Romiplostim Biological

Drug · Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2006
Primary completion
Nov 30, 2008
Completion
Jan 31, 2009
Last update posted
Oct 23, 2013

2006 – 2009

United States locations

U.S. sites
51
U.S. states
18
U.S. cities
25
Facility City State ZIP Site status
Research Site Glendale Arizona 85304
Research Site Glendale Arizona
Research Site Anaheim California 92801
Research Site Anaheim California
Research Site Los Angeles California 90048
Research Site Los Angeles California
Research Site Rancho Mirage California 92270
Research Site Rancho Mirage California
Research Site Boynton Beach Florida 33435
Research Site Boynton Beach Florida
Research Site Vero Beach Florida 32960
Research Site Vero Beach Florida
Research Site Athens Georgia 30607
Research Site Athens Georgia
Research Site Macon Georgia 31201
Research Site Macon Georgia
Research Site Peoria Illinois 61615
Research Site Peoria Illinois
Research Site Sioux City Iowa 51101
Research Site Sioux City Iowa
Research Site Paducah Kentucky 42003
Research Site Paducah Kentucky
Research Site Shreveport Louisiana 71101
Research Site Shreveport Louisiana
Research Site Baltimore Maryland 21201
Research Site Baltimore Maryland
Research Site Sterling Heights Michigan 48314
Research Site Sterling Heights Michigan
Research Site Billings Montana 59101
Research Site Billings Montana
Research Site Flemington New Jersey 08822
Research Site Flemington New Jersey
Research Site Johnson City New York 13790
Research Site Johnson City New York
Research Site Oklahoma City Oklahoma 73104
Research Site Oklahoma City Oklahoma
Research Site Drexel Hill Pennsylvania 19026
Research Site Drexel Hill Pennsylvania
Research Site Dunmore Pennsylvania 18512
Research Site Dunmore Pennsylvania
Research Site Radnor Pennsylvania 19087
Research Site Radnor Pennsylvania
Research Site Columbia South Carolina 29203
Research Site Columbia South Carolina
Research Site Germantown Tennessee 38138
Research Site Germantown Tennessee
Research Site Austin Texas 78705
Research Site Austin Texas
Research Site Houston Texas 77030
Research Site Houston Texas 77074
Research Site Houston Texas

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00413283, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 23, 2013 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00413283 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →